Sign in

CIK 0001579428 · Large accelerated filer

Axsome Therapeutics, Inc.

Sign in to watch
Ticker
AXSM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
454241907
Phone
(212) 332-3241
Business address
ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK, NY, 10007
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Planned sale Chief Financial Officer sold 15,000 shares at an average $130.10 ($1,951,530)
  8. 4 Option exercise Director acquired 9,127 shares (option exercise)
  9. 4 Option exercise Director acquired 33,410 shares (option exercise)
  10. 3 Insider Initial Statement of Ownership
  11. 4 Planned sale Director sold 11,016 shares at $91.31 ($1,005,871)
  12. 4 Planned sale Chief Operating Officer sold 47,739 shares at $84.26 ($4,022,488)
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Open-market sale Chief Operating Officer sold 7,910 shares at $74.31 ($587,813)
  18. 4 Planned sale Director sold 10,497 shares at an average $75.17 ($789,107)
  19. 4 Planned sale Chief Operating Officer sold 24,662 shares at $77.24 ($1,904,942)
  20. 4 Planned sale Director sold 32,323 shares at an average $69.84 ($2,257,449)

Page 4 of 11 · 211 filings